Figure 8From: Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD CD28nullCD137 + CD8- (clear bars) and CD28nullCD137 + CD8+ NKT-like cells (grey bars) producing TNFα in 10 control subjects (N) and 14 patients with COPD (C). Data presented as box plots. There was a trend for an increase in CD28nullCD137 + CD8+ NKT-like cells producing TNFα in patients with COPD compared with control subjects.Back to article page